{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:52:39Z","timestamp":1790650359002,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Angelini S.p.A.","award":["146MB16459"],"award-info":[{"award-number":["146MB16459"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.diagmicrobio.2019.114901","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T19:54:17Z","timestamp":1571169257000},"page":"114901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["In vitro time-kill kinetics of dalbavancin against Staphylococcus spp. biofilms over prolonged exposure times"],"prefix":"10.1016","volume":"96","author":[{"given":"Vincenzo","family":"Di Pilato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ceccherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanta","family":"Sennati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"D'Atanasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Di Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Tongiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Pallecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Maria","family":"Rossolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.diagmicrobio.2019.114901_bb0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.diagmicrobio.2018.10.007","article-title":"Dalbavancin for the management of gram-positive osteomyelitis: effectiveness and potential utility","volume":"93","author":"Almangour","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41579-018-0019-y","article-title":"Implant infections: adhesion, biofilm formation and immune evasion","volume":"16","author":"Arciola","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0015","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijantimicag.2013.05.019","article-title":"Activity of dalbavancin, alone and in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a foreign-body infection model","volume":"42","author":"Baldoni","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0020","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/jac\/dkv357","article-title":"Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis","volume":"71","author":"Barnea","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/QCO.0000000000000155","article-title":"Current concepts in pathogenesis of acute and chronic osteomyelitis","volume":"28","author":"Beck-Broichsitter","year":"2015","journal-title":"Curr Opin Infect Di"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/17453674.2017.1373497","article-title":"Bone and subcutaneous adipose tissue pharmacokinetics of vancomycin in total knee replacement patients","volume":"89","author":"Bue","year":"2018","journal-title":"Acta Orthop"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0035","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard. Document M07-Ed11","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2018"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0040","series-title":"Performance standards for antimicrobial susceptibility testing. Document M100-Ed28","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2018"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jinf.2004.05.006","article-title":"Dalbavancin compared with vancomycin for prevention of Staphylococcus aureus colonization of devices in vivo","volume":"50","author":"Darouiche","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0050","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/AAC.04550-14","article-title":"Extended-duration dosing and distribution of dalbavancin into bone and articular tissue","volume":"59","author":"Dunne","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0055","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.diagmicrobio.2016.05.009","article-title":"In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections","volume":"85","author":"Fern\u00e1ndez","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0060","doi-asserted-by":"crossref","first-page":"13849","DOI":"10.3390\/ijms150813849","article-title":"Antibacterial surface treatment for orthopaedic implants","volume":"15","author":"Gallo","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0065","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nprot.2010.71","article-title":"Microtiter susceptibility testing of microbes growing on peg lids: a miniaturized biofilm model for high-throughput screening","volume":"5","author":"Harrison","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0070","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00084-17","article-title":"Staphylococcal osteomyelitis: disease progression, treatment challenges, and future directions","volume":"31","author":"Kavanagh","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0075","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10096-016-2845-z","article-title":"Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)","volume":"36","author":"Knafl","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0080","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41426-018-0205-z","article-title":"Emergence of a dalbavancin induced glycopeptide\/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis","volume":"7","author":"Kussmann","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0085","doi-asserted-by":"crossref","first-page":"9661","DOI":"10.1038\/s41598-018-28006-8","article-title":"Dalbavancin for treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model","volume":"8","author":"Kussmann","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0090","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ijantimicag.2015.01.001","article-title":"Bactericidal activity of ceftaroline against mature Staphylococcus aureus biofilms","volume":"45","author":"Landini","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0095","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/MMBR.00013-14","article-title":"Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics","volume":"78","author":"Lebeaux","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0100","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1128\/AAC.01251-16","article-title":"Evaluation of antibiotics active against methicillin-resistant Staphylococcus aureus based on activity in an established biofilm","volume":"60","author":"Meeker","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02280-18","article-title":"Safety and efficacy of prolonged use of dalbavancin in bone and joint infections","volume":"63","author":"Morata","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.diagmicrobio.2017.09.015","article-title":"Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci","volume":"90","author":"Neudorfer","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0115","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1093\/jac\/dky235","article-title":"Activity of dalbavancin and comparator agents against gram-positive cocci from clinical infections in the USA and Europe 2015-16","volume":"73","author":"Pfaller","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1586\/14787210.2015.999669","article-title":"An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: new challenges for the present and the future","volume":"13","author":"Rodr\u00edguez-Pardo","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2019.114901_bb0125","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02397-17","article-title":"Antimicrobial activity of dalbavancin against Staphylococcus aureus with decreased susceptibility to glycopeptides, daptomycin, and\/or linezolid from U.S. Medical Centers","volume":"62","author":"Sader","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2019.114901_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijmm.2018.11.002","article-title":"An update on recent developments in the prevention and treatment of Staphylococcus aureus biofilms","volume":"309","author":"Suresh","year":"2019","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2019.114901_bb0135","first-page":"82","article-title":"Evaluation of dalbavancin alone and in combination with \u03b2-lactam antibiotics against resistant phenotypes of Staphylococcus aureus","volume":"74","author":"Xhemali","year":"2019","journal-title":"J Antimicrob Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288931930481X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288931930481X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:52:26Z","timestamp":1760003546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073288931930481X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S073288931930481X"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.114901","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro time-kill kinetics of dalbavancin against Staphylococcus spp. biofilms over prolonged exposure times","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.114901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114901"}}